Conference Coverage

AI flagged skin cancer with near-perfect accuracy, in UK study

November 1, 2023

Neoadjuvant, adjuvant, or both? The debate in NSCLC rages on

October 27, 2023

Lung Cancer

Two multitarget stool tests show promise for CRC screening: Studies

October 27, 2023

Colon and Rectal

Rare lymphomas: Desperately seeking new txs

October 27, 2023

‘We finally made it’: Amivantamab comes of age in NSCLC

October 26, 2023

Lung Cancer

Induction chemotherapy in first line improves survival for locally advanced cervical cancer

October 26, 2023

Ocular MALT lymphoma: Radiation reduces relapse

October 26, 2023

Mixed Topics

Frontline myeloma treatments: ASCT vs. CAR T

October 25, 2023

Multiple Myeloma

Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer

October 25, 2023

Breast Cancer

‘Why did I choose this?’ Tackling burnout in oncology

October 25, 2023

Mixed Topics

Enfortumab vedotin/pembrolizumab hailed as new standard for upfront mUC

October 25, 2023

Genitourinary Cancer

The sobering facts about alcohol and cancer

October 25, 2023

Chemo-immunotherapy good, adding a PARP inhibitor better in endometrial cancer?

October 23, 2023

ALK inhibitor alectinib shows DFS benefit in early NSCLC

October 22, 2023

Lung Cancer

Perioperative nivolumab improves EFS in resectable NSCLC

October 22, 2023

Lung Cancer